Highlight
The PRISM model offers an innovative, structured approach to classifying open-angle glaucoma (OAG) spanning from healthy individuals to end-stage disease. It integrates risk factor evaluation with advanced structural diagnostics and functional testing, introducing a dynamic disease progression modifier to guide monitoring intensity and therapeutic urgency.
